300832 Stock Overview
A bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Shenzhen New Industries Biomedical Engineering Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥63.56 |
| 52 Week High | CN¥97.20 |
| 52 Week Low | CN¥58.31 |
| Beta | -0.43 |
| 11 Month Change | -9.39% |
| 3 Month Change | -4.95% |
| 1 Year Change | -9.54% |
| 33 Year Change | 37.43% |
| 5 Year Change | n/a |
| Change since IPO | -31.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300832 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 0.3% | -3.4% | -2.6% |
| 1Y | -9.5% | -12.8% | 4.2% |
Return vs Industry: 300832 matched the CN Medical Equipment industry which returned -10.3% over the past year.
Return vs Market: 300832 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 300832 volatility | |
|---|---|
| 300832 Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300832 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300832's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,627 | Rao Wei | www.snibe.com |
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. It offers immunoassay, biochemistry/electrolyte, molecular diagnostics, point of care testing, lab automation, and integrated system, products. The company was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Fundamentals Summary
| 300832 fundamental statistics | |
|---|---|
| Market cap | CN¥49.94b |
| Earnings (TTM) | CN¥1.85b |
| Revenue (TTM) | CN¥4.44b |
27.0x
P/E Ratio11.3x
P/S RatioIs 300832 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300832 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.44b |
| Cost of Revenue | CN¥1.20b |
| Gross Profit | CN¥3.23b |
| Other Expenses | CN¥1.38b |
| Earnings | CN¥1.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 72.86% |
| Net Profit Margin | 41.72% |
| Debt/Equity Ratio | 0% |
How did 300832 perform over the long term?
See historical performance and comparison